Hypertension
📧 Sign up to get email alerts when something new happens for Hypertension.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2019-09-25FDA Approved: VERAPAMIL HYDROCHLORIDE — Supplemental Application (Nivagen Pharmaceuticals, Inc.)
The FDA approved a supplemental application for verapamil hydrochloride (generic) from Nivagen Pharmaceuticals, Inc., authorizing the sale o…
-
FDA approval · 2019-09-20FDA Approved: VALSARTAN — Supplemental Application (Amneal Pharmaceuticals LLC)
FDA approves a supplemental application for VALSARTAN by Amneal Pharmaceuticals LLC (ANDA 204011) to support the generic product.
-
FDA approval · 2019-09-17FDA Approved: THALITONE — Supplemental Application (Casper Pharma LLC)
The FDA approved a supplemental application for THALITONE (chlorthalidone) submitted by Casper Pharma LLC.
-
FDA approval · 2019-09-17FDA Approved: OLMESARTAN MEDOXOMIL — Original Application (Micro Labs Limited)
FDA approved the original application for olmesartan medoxomil from Micro Labs Limited, establishing a generic version of the antihypertensi…
-
FDA approval · 2019-09-17FDA Approved: OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE — Original Application (Lifestar Pharma LLC)
The FDA approved a generic combination tablet of olmesartan medoxomil and hydrochlorothiazide for hypertension. The applicant is Lifestar Ph…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2019-09-13FDA Approved: VALSARTAN — Supplemental Application (Alembic Pharmaceuticals Limited)
The FDA approved a supplemental application for valsartan from Alembic Pharmaceuticals Limited (ANDA 091367).
-
FDA approval · 2019-09-13FDA Approved: NADOLOL — Original Application (VGYAAN Pharmaceuticals LLC)
The FDA approved Nadolol as a generic product through an Original Application (ANDA) from VGYAAN Pharmaceuticals LLC. Nadolol is a non-selec…
-
FDA approval · 2019-09-10FDA Approved: VALSARTAN AND HYDROCHLOROTHIAZIDE — Supplemental Application (Alembic Pharmaceuticals Limited)
FDA granted a supplemental approval for the generic fixed-dose combination product valsartan and hydrochlorothiazide by Alembic Pharmaceutic…
-
FDA approval · 2019-09-09FDA Approved: TELMISARTAN AND AMLODIPINE — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for telmisartan and amlodipine from Mylan Pharmaceuticals, enabling the generic combination prod…
-
FDA approval · 2019-09-06FDA Approved: VALSARTAN AND HYDROCHLOROTHIAZIDE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for a generic fixed-dose combination of valsartan and hydrochlorothiazide by Mylan Pharmaceuticals, …
-
FDA approval · 2019-09-05FDA Approved: VALSARTAN AND HYDROCHLOROTHIAZIDE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Lupin Pharmaceuticals' valsartan and hydrochlorothiazide combination, making this generic pr…
-
FDA approval · 2019-09-04FDA Approved: VALSARTAN — Supplemental Application (Macleods Pharmaceuticals Limited)
The FDA approved a supplemental application for VALSARTAN submitted by Macleods Pharmaceuticals Limited, indicating approval of changes to t…
-
FDA approval · 2019-09-03FDA Approved: VALSARTAN — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' supplemental application for valsartan, a generic angiotensin II receptor blocker, for approved labeling…
-
FDA approval · 2019-09-03FDA Approved: VALSARTAN — Supplemental Application (SQUARE PHARMACEUTICALS LIMITED)
FDA approved a supplemental application for valsartan submitted by Square Pharmaceuticals Limited. This approval pertains to the generic pro…
-
FDA approval · 2019-08-20FDA Approved: VALSARTAN AND HYDROCHLOROTHIAZIDE — Supplemental Application (Macleods Pharmaceuticals Limited)
FDA approved a supplemental application for the generic combination valsartan and hydrochlorothiazide from Macleods Pharmaceuticals Limited.
-
FDA approval · 2019-08-20FDA Approved: VALSARTAN — Supplemental Application (Unichem Pharmaceuticals (USA), Inc.)
The FDA approved a supplemental application for VALSARTAN submitted by Unichem Pharmaceuticals (USA), Inc.
-
FDA approval · 2019-08-19FDA Approved: AMLODIPINE AND VALSARTAN — Supplemental Application (Lupin Pharmaceuticals, Inc.)
The FDA approved Lupin Pharmaceuticals' supplemental application for a fixed-dose combination of amlodipine and valsartan.
-
FDA approval · 2019-08-16FDA Approved: VALSARTAN AND HYDROCHLOROTHIAZIDE — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for a generic valsartan/hydrochlorothiazide combination tablet from Aurobindo Pharma Limited for…
-
FDA approval · 2019-08-16FDA Approved: IRBESARTAN — Supplemental Application (Camber Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Irbesartan from Camber Pharmaceuticals, indicating an approved change to the existing ANDA a…
-
FDA approval · 2019-08-07FDA Approved: IRBESARTAN AND HYDROCHLOROTHIAZIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for the generic combination product irbesartan and hydrochlorothiazide from Hikma Pharmaceuticals US…
-
FDA approval · 2019-08-07FDA Approved: ENALAPRIL MALEATE — Supplemental Application (Taro Pharmaceuticals U.S.A., Inc.)
FDA approves a supplemental application for enalapril maleate by Taro Pharmaceuticals U.S.A., Inc., pertaining to an approved product (gener…
-
FDA approval · 2019-08-06FDA Approved: CHLORTHALIDONE — Original Application (Unichem Pharmaceuticals (USA), Inc.)
FDA approved the original application for chlorthalidone from Unichem Pharmaceuticals (USA), Inc., enabling a generic version of the diureti…
-
FDA approval · 2019-08-05FDA Approved: SPIRONOLACTONE — Supplemental Application (Amneal Pharmaceuticals LLC)
FDA approved Amneal Pharmaceuticals LLC's supplemental application for spironolactone, enabling the marketing of a new generic product.
-
FDA approval · 2019-07-30FDA Approved: GUANFACINE — Supplemental Application (Sun Pharmaceutical Industries, Inc)
The FDA approved a supplemental application for guanfacine from Sun Pharmaceutical Industries, Inc., finalizing an updated approval for the …
-
FDA approval · 2019-07-25FDA Approved: SPIRONOLACTONE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for spironolactone submitted by Sun Pharmaceutical Industries, Inc., indicating an update to the…